r&d systems 产品目录--泽浩公司 |
r&d systems 产品目录列表 page 6 >> 1 2 3 4 5 6 7 8 9 10 >>..more |
产品编号 |
产品描述 |
规格/包装 |
品牌 |
694-gl-025/cf |
recombinant human gitr ligand/tnfsf18, cf (25 ug) |
25 ug |
r&d systems |
695-lt-025 |
recombinant human xcl1/lymphotactin (25 ug) |
25 ug |
r&d systems |
695-lt-025/cf |
recombinant human xcl1/lymphotactin, cf (25 ug) |
25 ug |
r&d systems |
696-cc-025 |
recombinant viral cci/fc chimera, cf (25 ug) |
25 ug |
r&d systems |
697-m3-025 |
recombinant viral mcv-type ii chemokine-like protein (25 ug) |
25 ug |
r&d systems |
697-m3-025/cf |
recombinant viral mcv-type ii chemokine-like protein, cf (25 ug) |
25 ug |
r&d systems |
701-ub-025 |
recombinant human his10 ubiquitin, cf (25 ug) |
25 ug |
r&d systems |
702-c2-010 |
recombinant human active caspase-2 (10 ug) |
10 ug |
r&d systems |
702-c2-010/cf |
recombinant human active caspase-2, cf (10 ug) |
10 ug |
r&d systems |
703-ub-025 |
recombinant human his10 ubiquitin 1, cf (25 ug) |
25 ug |
r&d systems |
704-ag-002 |
recombinant human agrp (2 ug) |
2 ug |
r&d systems |
705-c8-010 |
recombinant human caspase-8 (10 ug) |
10 ug |
r&d systems |
705-c8-010/cf |
recombinant human caspase-8, cf (10 ug) |
10 ug |
r&d systems |
707-c3-010 |
recombinant human caspase-3 (10 ug) |
10 ug |
r&d systems |
707-c3-010/cf |
recombinant human caspase-3, cf (10 ug) |
10 ug |
r&d systems |
708-mf-050 |
recombinant mouse fgf r2 beta (iiib)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
709-cch-010 |
human cytochrome c (human heart tissue), cf (10 ug) |
10 ug |
r&d systems |
710-mf-050 |
recombinant mouse fgf r3 (iiic)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
711-pg-010 |
recombinant porcine gm-csf (10 ug) |
10 ug |
r&d systems |
711-pg-010/cf |
recombinant porcine gm-csf, cf (10 ug) |
10 ug |
r&d systems |
712-fr-050 |
recombinant human fgf r2 alpha (iiic)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
715-ic-050 |
recombinant human icam-3/cd50/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
715-ic-200 |
recombinant human icam-3/cd50/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
716-mf-050 |
recombinant mouse fgf r2 beta (iiic)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
717-vc-025 |
recombinant human ccl28 (25 ug) |
25 ug |
r&d systems |
717-vc-025/cf |
recombinant human ccl28, cf (25 ug) |
25 ug |
r&d systems |
719-ng-050 |
recombinant mouse noggin/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
720-ic-050 |
recombinant human icam-1/cd54/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
720-ic-200 |
recombinant human icam-1/cd54/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
721-dr-100 |
recombinant mouse trail r2/tnfrsf10b/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
723-tr-100 |
recombinant mouse troy/tnfrsf19/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
724-es-100 |
recombinant human e-selectin (cd62e)/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
725-ck-025 |
recombinant mouse ccl27/ctack (25 ug) |
25 ug |
r&d systems |
725-ck-025/cf |
recombinant mouse ccl27/ctack, cf (25 ug) |
25 ug |
r&d systems |
726-r2-050 |
recombinant human tnf rii/tnfrsf1b/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
727-cd-100 |
recombinant mouse cd6/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
728-ls-100 |
recombinant human l-selectin/cd62l/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
730-xc-025 |
recombinant mouse cxcl14/brak, cf (25 ug) |
25 ug |
r&d systems |
731-c3-005 |
recombinant human pro-caspase-3, cf (5 ug) |
5 ug |
r&d systems |
732-cl-050 |
recombinant mouse cd30 ligand/tnfsf8 (50 ug) |
50 ug |
r&d systems |
732-cl-050/cf |
recombinant mouse cd30 ligand/tnfsf8, cf (50 ug) |
50 ug |
r&d systems |
735-cl-010 |
recombinant canine il-10 (10 ug) |
10 ug |
r&d systems |
735-cl-010/cf |
recombinant canine il-10, cf (10 ug) |
10 ug |
r&d systems |
736-fl-010 |
recombinant feline il-10 (10 ug) |
10 ug |
r&d systems |
736-fl-010/cf |
recombinant feline il-10, cf (10 ug) |
10 ug |
r&d systems |
737-ps-050 |
recombinant mouse p-selectin/cd62p/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
737-ps-200 |
recombinant mouse p-selectin/cd62p/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
738-an-025 |
recombinant mouse angiopoietin-3 (25 ug) |
25 ug |
r&d systems |
738-an-025/cf |
recombinant mouse angiopoietin-3, cf (25 ug) |
25 ug |
r&d systems |
740-b1-100 |
recombinant mouse b7-1/cd80/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
741-b2-100 |
recombinant mouse b7-2/cd86/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
743-r3-100 |
recombinant mouse vegf r3/flt-4/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
745-ed-050 |
recombinant mouse edar/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
746-lf-025 |
recombinant human lefty-a (25 ug) |
25 ug |
r&d systems |
746-lf-025/cf |
recombinant human lefty-a, cf (25 ug) |
25 ug |
r&d systems |
747-mr-050 |
recombinant mouse il-7 r alpha/cd127/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
748-ec-050 |
recombinant mouse e-cadherin/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
749-tb-025 |
recombinant mouse tnf-beta/tnfsf1b (25 ug) |
25 ug |
r&d systems |
749-tb-025/cf |
recombinant mouse tnf-beta/tnfsf1b, cf (25 ug) |
25 ug |
r&d systems |
751-ve-025 |
recombinant human vegf-b 167, cf (25 ug) |
25 ug |
r&d systems |
752-vc-025 |
recombinant human vegf-c (cys 156 ser) (25 ug) |
25 ug |
r&d systems |
752-vc-025/cf |
recombinant human vegf-c (cys 156 ser), cf (25 ug) |
25 ug |
r&d systems |
754-cl-025 |
recombinant canine il-4 (25 ug) |
25 ug |
r&d systems |
754-cl-025/cf |
recombinant canine il-4, cf (25 ug) |
25 ug |
r&d systems |
755-da-050 |
recombinant mouse dan (50 ug) |
50 ug |
r&d systems |
755-da-050/cf |
recombinant mouse dan, cf (50 ug) |
50 ug |
r&d systems |
756-tg-050 |
recombinant mouse twisted gastrulation (tsg) (50 ug) |
50 ug |
r&d systems |
756-tg-050/cf |
recombinant mouse twisted gastrulation (tsg), cf (50 ug) |
50 ug |
r&d systems |
758-cn-050/cf |
recombinant mouse chordin, cf (50 ug) |
50 ug |
r&d systems |
759-dt-100 |
recombinant mouse dtk/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
760-m3-025 |
recombinant mouse ccl20/mip-3 alpha (25 ug) |
25 ug |
r&d systems |
760-m3-025/cf |
recombinant mouse ccl20/mip-3 alpha, cf (25 ug) |
25 ug |
r&d systems |
761-mp-050 |
recombinant mouse p-cadherin/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
762-t2-100 |
recombinant mouse tie-2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
764-fg-050 |
recombinant feline ifn-gamma (50 ug) |
50 ug |
r&d systems |
764-fg-050/cf |
recombinant feline ifn-gamma, cf (50 ug) |
50 ug |
r&d systems |
765-fr-050 |
recombinant human fgf r1 beta (iiib)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
766-fr-050 |
recombinant human fgf r3 (iiic)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
767-ve-010 |
recombinant mouse vegf-b 186 (10 ug) |
10 ug |
r&d systems |
767-ve-010/cf |
recombinant mouse vegf-b 186, cf (10 ug) |
10 ug |
r&d systems |
768-f3-050 |
recombinant mouse flt-3/flk-2/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
769-fs-025 |
recombinant mouse follistatin 288 (fs-288) (25 ug) |
25 ug |
r&d systems |
769-fs-025/cf |
recombinant mouse follistatin 288 (fs-288), cf (25 ug) |
25 ug |
r&d systems |
770-ma-100 |
recombinant mouse alk-1/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
771-mr-100 |
recombinant mouse il-1 ri/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
774-m2-050 |
recombinant mouse icam-2/cd102/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
774-m2-200 |
recombinant mouse icam-2/cd102/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
775-b3-025 |
recombinant mouse igfbp-3, cf (25 ug) |
25 ug |
r&d systems |
776-b6-025 |
recombinant mouse igfbp-6, cf (25 ug) |
25 ug |
r&d systems |
777-nc-100 |
recombinant human ncam-l1/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
779-g7-010 |
recombinant mouse gdf-7 (10 ug) |
10 ug |
r&d systems |
779-g7-010/cf |
recombinant mouse gdf-7, cf (10 ug) |
10 ug |
r&d systems |
780-ra-025 |
recombinant porcine il-1ra/il-1f3 (25 ug) |
25 ug |
r&d systems |
780-ra-025/cf |
recombinant porcine il-1ra/il-1f3, cf (25 ug) |
25 ug |
r&d systems |
781-cg-050 |
recombinant canine ifn-gamma (50 ug) |
50 ug |
r&d systems |
781-cg-050/cf |
recombinant canine ifn-gamma, cf (50 ug) |
50 ug |
r&d systems |
782-il-010 |
recombinant human il-22 (10 ug) |
10 ug |
r&d systems |
782-il-010/cf |
recombinant human il-22, cf (10 ug) |
10 ug |
r&d systems |
783-cl-050 |
recombinant mouse cd27 ligand/tnfsf7 (50 ug) |
50 ug |
r&d systems |
783-cl-050/cf |
recombinant mouse cd27 ligand/tnfsf7, cf (50 ug) |
50 ug |
r&d systems |
784-mr-050 |
recombinant mouse common gamma chain/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
786-xb-050 |
recombinant human xiap (bir2), cf (50 ug) |
50 ug |
r&d systems |
787-lv-100 |
recombinant human livin beta/ml-iap, cf (100 ug) |
100 ug |
r&d systems |
788-g8-010 |
recombinant mouse gdf-8 (10 ug) |
10 ug |
r&d systems |
788-g8-010/cf |
recombinant mouse gdf-8, cf (10 ug) |
10 ug |
r&d systems |
789-sm-100 |
recombinant human smac/diablo, cf (100 ug) |
100 ug |
r&d systems |
791-mg-050 |
recombinant mouse igf-i, cf (50 ug) |
50 ug |
r&d systems |
792-mg-050 |
recombinant mouse igf-ii, cf (50 ug) |
50 ug |
r&d systems |
793-ck-025 |
recombinant mouse cxcl7/thymus chemokine-1 (25 ug) |
25 ug |
r&d systems |
793-ck-025/cf |
recombinant mouse cxcl7/thymus chemokine-1, cf (25 ug) |
25 ug |
r&d systems |
795-p4-025 |
recombinant human cxcl4/pf4 (25 ug) |
25 ug |
r&d systems |
795-p4-025/cf |
recombinant human cxcl4/pf4, cf (25 ug) |
25 ug |
r&d systems |
796-ic-050 |
recombinant mouse icam-1/cd54/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
797-b2-025 |
recombinant mouse igfbp-2, cf (25 ug) |
25 ug |
r&d systems |
800-ln-01m |
d-luciferin (1 mg) |
1 mg |
r&d systems |
800-ln-05m |
d-luciferin (5 mg) |
5 mg |
r&d systems |
800-ln-50m |
d-luciferin (50 mg) |
50 mg |
r&d systems |
801-cx-025 |
recombinant human cxcl13/blc/bca-1 (25 ug) |
25 ug |
r&d systems |
801-cx-025/cf |
recombinant human cxcl13/blc/bca-1, cf (25 ug) |
25 ug |
r&d systems |
802-hc-025 |
recombinant human ccl16/hcc-4 (25 ug) |
25 ug |
r&d systems |
802-hc-025/cf |
recombinant human ccl16/hcc-4, cf (25 ug) |
25 ug |
r&d systems |
803-i2-050 |
recombinant human icam-2/cd102/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
803-i2-200 |
recombinant human icam-2/cd102/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
804-gb-025 |
recombinant human igfbp-4, cf (25 ug) |
25 ug |
r&d systems |
805-os-100 |
recombinant human osteoprotegerin/tnfrsf11b/fc chimera (100 ug) |
100 ug |
r&d systems |
805-os-100/cf |
recombinant human osteoprotegerin/tnfrsf11b/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
807-uk-100 |
recombinant human upar (100 ug) |
100 ug |
r&d systems |
807-uk-100/cf |
recombinant human upar, cf (100 ug) |
100 ug |
r&d systems |
808-ar-100 |
recombinant human activin rib/alk-4/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
809-vr-050 |
recombinant human vcam-1/cd106, cf (50 ug) |
50 ug |
r&d systems |
809-vr-200 |
recombinant human vcam-1/cd106, cf (200 ug) |
200 ug |
r&d systems |
811-br-100 |
recombinant human bmpr-ii/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
813-cd-100 |
recombinant human cd30/tnfrsf8/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
816-lr-100 |
recombinant human il-18 r alpha/il-1 r5/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
817-p2-050 |
recombinant human ciap-2 (hiap), cf (50 ug) |
50 ug |
r&d systems |
818-ia-050 |
recombinant human ciap-1 (hiap), cf (50 ug) |
50 ug |
r&d systems |
822-xf-050 |
recombinant human xiap (full length), cf (50 ug) |
50 ug |
r&d systems |
823-c7-010 |
recombinant human caspase-7 (10 ug) |
10 ug |
r&d systems |
823-c7-010/cf |
recombinant human caspase-7, cf (10 ug) |
10 ug |
r&d systems |
824-bw-050 |
recombinant human bcl-w (minus c-terminus), cf (50 ug) |
50 ug |
r&d systems |
827-bc-050 |
recombinant human bcl-2 (minus c-terminus), cf (50 ug) |
50 ug |
r&d systems |
834-cp-010 |
recombinant human caspase-10/a (mch 4), cf (10 ug) |
10 ug |
r&d systems |
838-4b-100 |
recombinant human 4-1bb/tnfrsf9/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
839-b1-100 |
recombinant human il-12 r beta 1/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
844-dc-050 |
recombinant mouse dcc/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
845-tc-025 |
recombinant mouse ccl1/tca-3 (25 ug) |
25 ug |
r&d systems |
845-tc-025/cf |
recombinant mouse ccl1/tca-3, cf (25 ug) |
25 ug |
r&d systems |
846-bd-050 |
recombinant human bid, cf (50 ug) |
50 ug |
r&d systems |
847-pn-010 |
recombinant human active pten, cf (10 ug) |
10 ug |
r&d systems |
852-cd-100 |
recombinant mouse cd30/tnfrsf8/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
853-g5-050 |
recombinant mouse gdf-5 (50 ug) |
50 ug |
r&d systems |
853-g5-050/cf |
recombinant mouse gdf-5, cf (50 ug) |
50 ug |
r&d systems |
854-ax-100 |
recombinant mouse axl/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
855-g6-050 |
recombinant mouse gdf-6 (50 ug) |
50 ug |
r&d systems |
855-g6-050/cf |
recombinant mouse gdf-6, cf (50 ug) |
50 ug |
r&d systems |
859-dk-100 |
recombinant human dtk/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
860-mb-050 |
recombinant mouse bid, cf (50 ug) |
50 ug |
r&d systems |
861-pc-100 |
recombinant human p-cadherin/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
862-vc-100 |
recombinant human vcam-1/cd106/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
866-cx-025 |
recombinant human cxcl14/brak, cf (25 ug) |
25 ug |
r&d systems |
869-p3-050 |
recombinant human p38 alpha (unactive), cf (50 ug) |
50 ug |
r&d systems |
870-lp-025 |
recombinant human lbp (25 ug) |
25 ug |
r&d systems |
870-lp-025/cf |
recombinant human lbp, cf (25 ug) |
25 ug |
r&d systems |
871-b1-025 |
recombinant human igfbp-1, cf (25 ug) |
25 ug |
r&d systems |
872-rp-100 |
recombinant human il-1 r6/il-1 r rp2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
873-lp-050 |
recombinant human lamp/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
874-rb-100 |
recombinant human il-10 r beta/fc chimera,cf (100 ug) |
100 ug |
r&d systems |
875-b5-025 |
recombinant human igfbp-5, cf (25 ug) |
25 ug |
r&d systems |
876-b6-025 |
recombinant human igfbp-6, cf (25 ug) |
25 ug |
r&d systems |
878-bc-050 |
recombinant mouse bcl-xl (minus c-terminus), cf (50 ug) |
50 ug |
r&d systems |
879-bk-100 |
recombinant human bak bh3 (l78a) domain, cf (100 ug) |
100 ug |
r&d systems |
881-ba-100 |
recombinant human bak bh3 domain, cf (100 ug) |
100 ug |
r&d systems |
882-b8-050 |
recombinant human bid (caspase-8-cleaved), cf (50 ug) |
50 ug |
r&d systems |
883-m8-050 |
recombinant mouse bid (caspase-8-cleaved), cf (50 ug) |
50 ug |
r&d systems |
884-ap-010 |
recombinant human april/tnfsf13 (10 ug) |
10 ug |
r&d systems |
884-ap-010/cf |
recombinant human april/tnfsf13, cf (10 ug) |
10 ug |
r&d systems |
885-gs-050 |
recombinant human gas6, cf |
50 µg |
r&d systems |
891-mr-100 |
recombinant human mer/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
894-bx-050 |
recombinant human bcl-xl (minus c-terminus), cf (50 ug) |
50 ug |
r&d systems |
895-xb-050 |
recombinant human xiap (bir3), cf (50 ug) |
50 ug |
r&d systems |
901-mp-010 |
recombinant human mmp-1, cf (10 ug) |
10 ug |
r&d systems |
902-mp-010 |
recombinant human mmp-2, cf (10 ug) |
10 ug |
r&d systems |
902-mpn-010 |
recombinant human mmp-2 (nso-expressed), cf (10 ug) |
10 ug |
r&d systems |
904-cn-100 |
recombinant human contactin-1/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
907-mp-010 |
recombinant human mmp-7, cf (10 ug) |
10 ug |
r&d systems |
908-mp-010 |
recombinant human mmp-8, cf (10 ug) |
10 ug |
r&d systems |
909-mm-010 |
recombinant mouse/rat mmp-9, cf (10 ug) |
10 ug |
r&d systems |
910-mp-010 |
recombinant human mmp-10, cf (10 ug) |
10 ug |
r&d systems |
911-mp-010 |
recombinant human mmp-9, cf (10 ug) |
10 ug |
r&d systems |
911-mpn-010 |
recombinant human mmp-9 (nso-expressed), cf (10 ug) |
10 ug |
r&d systems |
912-pl-025 |
recombinant porcine il-12 (25 ug) |
25 ug |
r&d systems |
912-pl-025/cf |
recombinant porcine il-12, cf (25 ug) |
25 ug |
r&d systems |
915-vl-010 |
recombinant viral ebv il-10 (10 ug) |
10 ug |
r&d systems |
915-vl-010/cf |
recombinant viral ebv il-10, cf (10 ug) |
10 ug |
r&d systems |
917-mp-010 |
recombinant human mmp-12 (aa 1-470), cf (10 ug) |
10 ug |
r&d systems |
918-mp-010 |
recombinant human mmp-14, cf (10 ug) |
10 ug |
r&d systems |
922-ed-010 |
recombinant human eda-a2 (10 ug) |
10 ug |
r&d systems |
922-ed-010/cf |
recombinant human eda-a2, cf (10 ug) |
10 ug |
r&d systems |
923-an-025 |
recombinant human angiopoietin-1 (25 ug) |
25 ug |
r&d systems |
923-an-025/cf |
recombinant human angiopoietin-1, cf (25 ug) |
25 ug |
r&d systems |
924-mp-010 |
recombinant mouse mmp-2, cf (10 ug) |
10 ug |
r&d systems |
925-md-050 |
recombinant human md-1 (50 ug) |
50 ug |
r&d systems |
925-md-050/cf |
recombinant human md-1, cf (50 ug) |
50 ug |
r&d systems |
927-ly-010 |
recombinant mouse lymphotoxin alpha1/beta2 (10 ug) |
10 ug |
r&d systems |
927-ly-010/cf |
recombinant mouse lymphotoxin alpha1/beta2, cf (10 ug) |
10 ug |
r&d systems |
928-t2-100 |
recombinant zebrafish tie-2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
929-zn-010 |
recombinant human ace, cf (10 ug) |
10 ug |
r&d systems |
930-adb-010 |
recombinant human tace/adam17, cf (10 ug) |
10 ug |
r&d systems |
931-as-050 |
recombinant human bace-1, cf (50 ug) |
50 ug |
r&d systems |
933-zn-010 |
recombinant human ace-2, cf (10 ug) |
10 ug |
r&d systems |
934-cy-010 |
recombinant human cathepsin x/z/p, cf (10 ug) |
10 ug |
r&d systems |
936-ad-020 |
recombinant human adam10, cf (20 ug) |
20 ug |
r&d systems |
937-4b-050 |
recombinant mouse 4-1bb/tnfrsf9/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
938-vc-050 |
recombinant human ve-cadherin/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
939-ad-020 |
recombinant human adam9, cf (20 ug) |
20 ug |
r&d systems |
942-sp-050 |
recombinant mouse sparc, cf (50 ug) |
50 ug |
r&d systems |
943-d3-050 |
recombinant human dr3/tnfrsf25/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
944-dm-100 |
recombinant human desmoglein-1/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
946-ad-020 |
recombinant mouse adam10, cf (20 ug) |
20 ug |
r&d systems |
947-dm-100 |
recombinant human desmoglein-2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
949-ad-020 |
recombinant mouse adam9, cf (20 ug) |
20 ug |
r&d systems |
9510-01k-eb |
tdt enzyme/buffer |
1000 u |
r&d systems |
952-cy-010 |
recombinant human cathepsin l, cf (10 ug) |
10 ug |
r&d systems |
953-cy-010 |
recombinant human cathepsin b, cf (10 ug) |
10 ug |
r&d systems |
954-se-010 |
recombinant mouse dppiv/cd26, cf (10 ug) |
10 ug |
r&d systems |
955-da-050 |
recombinant human dan/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
956-gr-050 |
recombinant mouse gremlin (50 ug) |
50 ug |
r&d systems |
956-gr-050/cf |
recombinant mouse gremlin, cf (50 ug) |
50 ug |
r&d systems |
957-gd-025 |
recombinant human gdf-15 (25 ug) |
25 ug |
r&d systems |
957-gd-025/cf |
recombinant human gdf-15, cf (25 ug) |
25 ug |
r&d systems |
958-g3-010 |
recombinant mouse gdf-3, cf |
10 µg |
r&d systems |
958-g3-010 |
recombinant mouse gdf-3, cf (10 ug) |
10 ug |
r&d systems |
959-me-010 |
recombinant mouse erythropoietin (10 ug) |
10 ug |
r&d systems |
959-me-010/cf |
recombinant mouse erythropoietin, cf (10 ug) |
10 ug |
r&d systems |
960-ep-050 |
recombinant human epcam/trop1/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
961-rm-025 |
recombinant rhesus macaque ifn-gamma (25 ug) |
25 ug |
r&d systems |
961-rm-025/cf |
recombinant rhesus macaque ifn-gamma, cf (25 ug) |
25 ug |
r&d systems |
962-cl-050 |
recombinant human clc (50 ug) |
50 ug |
r&d systems |
962-cl-050/cf |
recombinant human clc, cf (50 ug) |
50 ug |
r&d systems |
963-er-050 |
recombinant human erythropoietin r/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
964-an-025 |
recombinant human angiopoietin-4 (25 ug) |
25 ug |
r&d systems |
964-an-025/cf |
recombinant human angiopoietin-4, cf (25 ug) |
25 ug |
r&d systems |
965-cy-010 |
recombinant mouse cathepsin b, cf (10 ug) |
10 ug |
r&d systems |
966-6c-025 |
recombinant human ccl21/6ckine (mucin stalk chimera) (25 ug) |
25 ug |
r&d systems |
966-6c-025/cf |
recombinant human ccl21/6ckine (mucin stalk chimera), cf (25 ug) |
25 ug |
r&d systems |
968-il-025 |
recombinant human cxcl8/il-8 (mucin stalk chimera) (25 ug) |
25 ug |
r&d systems |
968-il-025/cf |
recombinant human cxcl8/il-8 (mucin stalk chimera), cf (25 ug) |
25 ug |
r&d systems |
969-fg-025 |
recombinant human fgf-19 (25 ug) |
25 ug |
r&d systems |
969-fg-025/cf |
recombinant human fgf-19, cf (25 ug) |
25 ug |
r&d systems |
970-tm-010 |
recombinant human timp-1, cf (10 ug) |
10 ug |
r&d systems |
971-tm-010 |
recombinant human timp-2, cf (10 ug) |
10 ug |
r&d systems |
972-emn-050 |
recombinant human emmprin/fc chimera (ns0-expressed), cf (50 ug) |
50 ug |
r&d systems |
973-tm-010 |
recombinant human timp-3, cf (10 ug) |
10 ug |
r&d systems |
974-tsf-010 |
recombinant human timp-4 (sf21-expressed), cf (10 ug) |
10 ug |
r&d systems |
976-cx-025 |
recombinant human cxcl16 (25 ug) |
25 ug |
r&d systems |
976-cx-025/cf |
recombinant human cxcl16, cf (25 ug) |
25 ug |
r&d systems |
977-es-100 |
recombinant rat e-selectin (cd62e)/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
978-rn-025 |
recombinant human ccl5/rantes (mucin stalk chimera) (25 ug) |
25 ug |
r&d systems |
978-rn-025/cf |
recombinant human ccl5/rantes (mucin stalk chimera), cf (25 ug) |
25 ug |
r&d systems |
979-mc-025 |
recombinant human ccl2/mcp-1 (mucin stalk chimera) (25 ug) |
25 ug |
r&d systems |
979-mc-025/cf |
recombinant human mcp-1/ccl2 (mucin stalk chimera), cf (25 ug) |
25 ug |
r&d systems |
980-mt-010 |
recombinant mouse timp-1, cf (10 ug) |
10 ug |
r&d systems |
981-tr-050 |
recombinant human tslp r/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
982-cd-100 |
recombinant mouse cd14/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
983-mr-100 |
recombinant mouse il-3 r alpha/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
984-fl-025 |
recombinant feline il-4 (25 ug) |
25 ug |
r&d systems |
984-fl-025/cf |
recombinant feline il-4, cf (25 ug) |
25 ug |
r&d systems |
985-pi-050 |
recombinant porcine ifn-gamma (50 ug) |
50 ug |
r&d systems |
985-pi-050/cf |
recombinant porcine ifn-gamma, cf (50 ug) |
50 ug |
r&d systems |
986-gs-025 |
recombinant mouse gas 6 (25 ug) |
25 ug |
r&d systems |
986-gs-025/cf |
recombinant mouse gas 6, cf (25 ug) |
25 ug |
r&d systems |
987-fl-010 |
recombinant feline gm-csf (10 ug) |
10 ug |
r&d systems |
987-fl-010/cf |
recombinant feline gm-csf, cf (10 ug) |
10 ug |
r&d systems |
988-vj-050 |
recombinant mouse jam-b/ve-jam/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
989-ar-100 |
recombinant mouse amphiregulin (100 ug) |
100 ug |
r&d systems |
989-ar-100/cf |
recombinant mouse amphiregulin, cf (100 ug) |
100 ug |
r&d systems |
990-sg-100 |
recombinant human sigirr/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
991-r2-100 |
recombinant human il-21 r/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
992-sg-100 |
recombinant mouse sigirr/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
993-mc-050 |
recombinant mouse madcam-1/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
994-lf-025 |
recombinant mouse lefty-1/his chimera (25 ug) |
25 ug |
r&d systems |
994-lf-025/cf |
recombinant mouse lefty-1/his chimera, cf (25 ug) |
25 ug |
r&d systems |
ab-100-na |
tgf-beta pan specific polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-101-c |
normal chicken igy (1 mg) |
1 mg |
r&d systems |
ab-101-na |
tgf-beta 1/1.2 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-105-c |
rabbit igg control (1 mg) |
1 mg |
r&d systems |
ab-108-c |
goat igg control (1 mg) |
1 mg |
r&d systems |
ab-112-na |
tgf-beta 2 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab126 |
human fas ligand/tnfsf6 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-12-na |
tgf-beta 2 polyclonal ab (rabbit) (1 mg) |
1 mg |
r&d systems |
ab1536 |
human/mouse hif-1 alpha polyclonal ab (100 ug) |
100 ug |
r&d systems |
ab1537 |
tor polyclonal ab (100 ug) |
100 ug |
r&d systems |
ab-200-na |
human il-1 alpha/il-1f1 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-201-na |
human il-1 beta/il-1f2 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-202-na |
human il-2 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-203-na |
human il-3 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-204-na |
human il-4 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-205-na |
human il-5 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-206-na |
human il-6 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-207-na |
human il-7 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-208-na |
human cxcl8/il-8 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-209-na |
human il-9 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-20-na |
human pdgf polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-210-na |
human tnf-alpha/tnfsf1a polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-211-na |
human tnf-beta/tnfsf1b polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-212-na |
human gdnf polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-214-na |
human g-csf polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-215-na |
human gm-csf polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-216-na |
human m-csf polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-217-na |
human il-10 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-218-na |
human il-11 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-219-na |
human il-12 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-220-na |
human pdgf-bb polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-221-na |
human pdgf-aa polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-223-na |
human il-2 r alpha polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-225-pb |
human tnf ri/tnfrsf1a polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-226-pb |
human tnf rii/tnfrsf1b polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-227-na |
human il-6 r polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-228-na |
human gp130 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-229-na |
human pd-ecgf polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-230-na |
human il-4 sr polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-233-na |
human fgf basic polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-235-na |
human fgf-4 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-236-na |
human egf polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-238-na |
human fgf-6 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-239-na |
human tgf-alpha polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-23-na |
pdgf polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-244-na |
tgf-beta 3 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-245-na |
tgf-beta 5 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-246-na |
human lap (tgf-beta 1) polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-247-na |
human il-15 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-250-na |
human lif polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-254-pb |
human cxcl5/ena-78 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-255-na |
human scf polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-256-na |
human beta-ngf polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-257-na |
human cntf polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-260-na |
human slpi polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-261-na |
human betacellulin polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-262-na |
human amphiregulin polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-264-pb |
human plgf polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-265-na |
human angiogenin polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-266-pb |
human cxcl10/ip-10 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-269-na |
human il-1 ri polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-270-na |
human ccl3/mip-1 alpha polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-271-na |
human ccl4/mip-1 beta polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-272-pb |
human ccl1/i-309 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-275-pb |
human cxcl1/gro alpha polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-278-na |
human ccl5/rantes polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-279-na |
human ccl2/mcp-1 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-280-na |
human il-1ra/il-1f3 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-281-na |
human ccl8/mcp-2 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-282-na |
human ccl7/mcp-3 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-285-na |
human ifn-gamma polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-286-na |
human erythropoietin polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-288-na |
human thrombopoietin polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-289-pb |
human mif polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-293-na |
human vegf polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-294-na |
human hgf polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-295-na |
human oncostatin m (osm) polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab3010 |
human porimin polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab3226 |
human phospho-smad3 (s423/s425) polyclonal ab (250 ul) |
250 ul |
r&d systems |
ab-32-na |
bovine fgf acidic polyclonal ab (rabbit) (1 mg) |
1 mg |
r&d systems |
ab-33-na |
bovine fgf basic polyclonal ab (rabbit) (1 mg) |
1 mg |
r&d systems |
ab383 |
human cd14 polyclonal ab (500 ug) |
500 ug |
r&d systems |
ab-400-na |
mouse il-1 alpha/il-1f1 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-401-na |
mouse il-1 beta/il-1f2 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-402-na |
mouse il-2 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-403-na |
mouse il-3 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-404-na |
mouse il-4 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-405-na |
mouse il-5 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-406-na |
mouse il-6 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-407-na |
mouse il-7 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-409-na |
mouse il-9 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-410-na |
mouse tnf-alpha/tnfsf1a polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-413-na |
mouse il-13 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-414-na |
mouse g-csf polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-415-na |
mouse gm-csf polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-416-na |
mouse m-csf polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-417-na |
mouse il-10 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-419-na |
mouse il-12 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-449-na |
mouse lif polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-450-na |
mouse ccl3/mip-1 alpha polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-451-na |
mouse ccl4/mip-1 beta polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-455-na |
mouse scf polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-479-na |
mouse ccl2/je/mcp-1 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-487-na |
mouse ccl6/c10 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab-557-na |
rat cntf polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab623 |
human angiopoietin-2 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab626 |
human trance/rank l polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab820 |
human bax polyclonal ab (400 ug) |
400 ug |
r&d systems |
ab885 |
human gas6 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab911 |
human mmp-9 polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab924 |
human/mouse mmp-24 (mt5-mmp) polyclonal ab (200 ug) |
200 ug |
r&d systems |
ab936 |
human adam10 ectodomain polyclonal ab (1 mg) |
1 mg |
r&d systems |
ab946 |
mouse adam10 ectodomain polyclonal ab (1 mg) |
1 mg |
r&d systems |
adp1-050 |
recombinant human e-selectin/cd62e, cf (50 ug) |
50 ug |
r&d systems |
adp1-200 |
recombinant human e-selectin/cd62e, cf (200 ug) |
200 ug |
r&d systems |
adp2-050 |
recombinant human l-selectin/cd62l, cf (50 ug) |
50 ug |
r&d systems |
adp2-200 |
recombinant human l-selectin/cd62l, cf (200 ug) |
200 ug |
r&d systems |
adp3-050 |
recombinant human p-selectin/cd62p, cf (50 ug) |
50 ug |
r&d systems |
adp3-200 |
recombinant human p-selectin/cd62p, cf (200 ug) |
200 ug |
r&d systems |
adp4-050 |
recombinant human icam-1/cd54, cf (50 ug) |
50 ug |
r&d systems |
adp4-200 |
recombinant human icam-1/cd54, cf (200 ug) |
200 ug |
r&d systems |
adp5-050 |
recombinant human vcam-1/cd106, cf (50 ug) |
50 ug |
r&d systems |
adp5-200 |
recombinant human vcam-1/cd106, cf (200 ug) |
200 ug |
r&d systems |
adp6-200 |
recombinant human cd31 (pecam-1), cf (200 ug) |
200 ug |
r&d systems |
af005 |
goat anti-rat igg unlabeled affinity purified pab (500 ug) |
500 ug |
r&d systems |
af007 |
goat anti-mouse igg unlabeled affinity purified pab (500 ug) |
500 ug |
r&d systems |
af008 |
goat anti-rabbit igg unlabeled affinity purified pab (500 ug) |
500 ug |
r&d systems |
af009 |
human neurophysin ii affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af010 |
goat anti-chicken igy unlabeled affinity purified pab (500 ug) |
500 ug |
r&d systems |
af1001 |
mouse frizzled-3 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1002 |
mouse ve-cadherin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1003 |
human tgf-beta riib affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1004 |
mouse il-1 r4/st2l affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1005 |
human unc5h3 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1006 |
rat unc5h2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1007 |
human il-1 r9 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1008 |
mouse lymphotaxin beta r/tnfrsf3 affinity purified pab (100 ug) |
100 ug |
r&d systems |
af1009 |
cotton rat il-1 beta/il-1f2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1010 |
cotton rat ccl5/rantes affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1011 |
cotton rat tnf-alpha/tnfsf1a affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1013 |
mouse cathepsin h affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1014 |
human cathepsin d affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1016 |
human thrombopoietin r affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1018 |
phospho-erk1/erk2 (t202/y204) affinity purified pab (100 ug) |
100 ug |
r&d systems |
af1019 |
mouse b7-h1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af-101-na |
tgf-beta 1/1.2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1021 |
mouse pd-1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1022 |
mouse pd-l2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1024 |
cotton rat ccl4/mip-1 beta affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1025 |
mouse betacellulin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1026 |
mouse ifn-gamma r1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1027 |
human b7-h3 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1028 |
human cd30 ligand/tnfsf8 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1029 |
mouse cathepsin d affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1031 |
human adam8 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1032 |
human cadherin-17 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1033 |
mouse cathepsin x/z/p affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1034 |
mouse cathepsin c/dppi affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1035 |
human il-19 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1036 |
phospho-msk1 (s212) affinity purified pab (100 ug) |
100 ug |
r&d systems |
af1039 |
human 2b4/cd244/slamf4 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1040 |
mouse il-17b r affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1041 |
mouse taci/tnfrsf13b affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1042 |
mouse pdgf r beta affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1043 |
human phospho-p53 (s15) affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1044 |
human/mouse/rat ape affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1047 |
human p21/cip1/cdkn1a affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1048 |
human hai-1 ectodomain affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1049 |
human cathepsin a affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1050 |
mouse 2b4/cd244/slamf4 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1051 |
chicken caronte affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1052 |
human en-rage affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1053 |
mouse glypican 6 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1054 |
human ox40 ligand/tnfsf4 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1055 |
rat pdgf-aa affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1056 |
rat trka affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1057 |
rat notch-1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1060 |
mouse decorin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1061 |
cotton rat ccl3/mip-1 alpha affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1062 |
mouse pdgf r alpha affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1065 |
human adiponectin/acrp30 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1067 |
human growth hormone (gh) affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1068 |
mouse epiregulin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1069 |
mouse resistin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1070 |
rhesus macaque tnf-alpha affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1071 |
human cathepsin c/dppi affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1072 |
human siglec-5 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1073 |
human bmp-8 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1074 |
human jam-b/ve-jam affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1075 |
human cerberus 1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1077 |
mouse jam-a affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1078 |
human il-1f6/fil1 epsilon affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1079 |
mouse neogenin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1080 |
human cathepsin v affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1082 |
cotton rat ifn-alpha affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1083 |
mouse ifn-alpha/beta r2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1085 |
mouse artemin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1086 |
human pd-1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1087 |
human il-22bp affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1088 |
zebrafish ephrin-b2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af109 |
donkey anti-goat igg unlabeled affinity purified pab (500 ug) |
500 ug |
r&d systems |
af1090 |
human tweak/tnfsf12 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1092 |
mouse sigirr affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1093 |
human xedar affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1094 |
phospho-msk1 (s376)/msk2 (s360) affinity purified pab (100 ug) |
100 ug |
r&d systems |
af1095 |
human phospho-egf r (y1173) affinity purified polyclonal ab (50 ug) |
50 ug |
r&d systems |
af1096 |
human dkk-1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1097 |
human endoglin/cd105 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1098 |
human endostatin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1099 |
human il-1f8/fil1 eta affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1102 |
human il-20 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1103 |
human jam-a affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1105 |
rat hepassocin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1106 |
human hai-2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1107 |
mouse hai-2 ectodomain affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1108 |
human kallikrein 5 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1109 |
mouse netrin-1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1112 |
rat prolactin r affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1116 |
rat cxcl7/thymus chemokine-1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1117 |
cotton rat cxcl10/ip-10 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1118 |
human dkk-3 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1119 |
mouse adiponectin/acrp30 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af112 |
mouse frizzled-8 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1120 |
mouse frizzled-1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1121 |
mouse trail/tnfsf10 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1122 |
mouse trop-2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1126 |
mouse neprilysin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1127 |
mouse epigen affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1129 |
human erbb2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af113 |
human bmp-3 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1130 |
mouse cathepsin e affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1131 |
human erbb4 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1132 |
mouse netrin-4 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1136 |
mouse rae-1 gamma affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1138 |
human siglec-7 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1139 |
human siglec-9 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af114 |
mouse cd45 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1141 |
mouse hai-1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1143 |
human pd-ecgf affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1144 |
human pref-1/dlk-1/fa1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1145 |
human rage affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1146 |
human semaphorin 6a affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1148 |
human factor ii/thrombin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1149 |
mouse serpin f1/pedf affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1152 |
human galectin-1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1153 |
human galectin-2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1154 |
human galectin-3 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1155 |
mouse h60 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1157 |
mouse ngf r/tnfrsf16 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1159 |
human pdgf-d affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1161 |
human livin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1162 |
human baff r/tnfrsf13c affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1163 |
mouse cd40 ligand/tnfsf5 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1166 |
mouse netrin-g1a affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1167 |
human prolactin r affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1168 |
human app pan specific affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1169 |
mouse sfrp-2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af117 |
viral hcmv il-10 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1172 |
mouse alcam affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1173 |
mouse icam-5 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1174 |
human cathepsin o affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1176 |
human il-20 r alpha affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1177 |
human serpin f1/pedf affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1179 |
mouse rage affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af118 |
human il-18 r beta/il-1 r7 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1180 |
human dppiv/cd26 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1182 |
human neprilysin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1183 |
human cathepsin s affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1184 |
human fetuin a/ahsg affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1185 |
mouse ifn-gamma r2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1187 |
mouse trem-1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1188 |
rat gaba-b-r2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1189 |
human jam-c affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af119 |
human il-18 bpa affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1190 |
rat notch-2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1195 |
human epiregulin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1196 |
human cystatin c affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1197 |
mouse galectin-3 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1199 |
human tweak r/tnfrsf12 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1202 |
human cystatin d affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1204 |
mouse il-20 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1205 |
phospho-jnk (t183/y185) affinity purified pab (50 ug) |
50 ug |
r&d systems |
af1206 |
human fgf-3 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1207 |
human il-17b r affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1208 |
human nogo receptor affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1209 |
human eg-vegf/pk1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1210 |
human growth hormone r (ghr) affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1211 |
rat growth hormone r (ghr) affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1212 |
human fgf-16 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1213 |
mouse jam-c affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1214 |
rat b7-1/cd80 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1219 |
human integrin alpha v/cd51 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af122 |
mouse il-18 bpd affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1220 |
human aggrecan affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1224 |
human pd-l2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1226 |
mouse sca-1/ly6 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1227 |
human galectin-4 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af123 |
human cd23/fc epsilon rii affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1230 |
human/mouse/rat erk2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af12301 |
human/mouse/rat erk2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1234 |
human il-17c affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1235 |
human neurotrimin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1236 |
mouse ox40 ligand/tnfsf4 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1237 |
mouse tweak/tnfsf12 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1238 |
mouse cystatin c affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1239 |
mouse serpin f2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af124 |
human baff/blys/tnfsf13b affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1240 |
mouse igfbp-1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1244 |
human/mouse/rat mdm2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1245 |
mouse galectin-1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1246 |
mouse 4-1bb ligand/tnfsf9 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1247 |
zebrafish vegf affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
af1248 |
human il-17b affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
r&d systems 产品目录列表 page 6 >> 1 2 3 4 5 6 7 8 9 10 >>..more |